Garrett Gruener - Net Worth and Insider Trading

Garrett Gruener Net Worth

The estimated net worth of Garrett Gruener is at least $2,519 dollars as of 2024-05-23. Garrett Gruener is the Director, 10% Owner of Nanomix Corp and owns about 25,186,338 shares of Nanomix Corp (NNMX) stock worth over $2,519. Details can be seen in Garrett Gruener's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Garrett Gruener has not made any transactions after 2022-12-09 and currently still holds the listed stock(s).

Transaction Summary of Garrett Gruener

Garrett Gruener Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Garrett Gruener owns 9 companies in total, including Ellie Mae Inc (ELLI) , Raptor Pharmaceutical Corp (RPTP) , and NeurogesX Inc (NGSX) among others .

Click here to see the complete history of Garrett Gruener’s form 4 insider trades.

Insider Ownership Summary of Garrett Gruener

Ticker	Comapny	Transaction Date	Type of Owner
ELLI	Ellie Mae Inc	2011-04-20	10 percent owner
RPTP	Raptor Pharmaceutical Corp	2009-09-03	other: No longer 10% owner
NGSX	NeurogesX Inc	2007-05-07	10 percent owner
		2005-02-23	other: No longer 10% Owner
		2004-03-31	10 percent owner
		2004-03-22	other: See Footnote #2
		2004-02-19	other: See footnotes
		2003-08-27	10 percent owner
		2022-12-09	director & 10 percent owner

Garrett Gruener Latest Holdings Summary

Garrett Gruener currently owns a total of 1 stock. Garrett Gruener owns 25,186,338 shares of Nanomix Corp (NNMX) as of December 9, 2022, with a value of $2,519.

Latest Holdings of Garrett Gruener

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NNMX	Nanomix Corp	2022-12-09	25,186,338	0.00	2,519

Holding Weightings of Garrett Gruener

Garrett Gruener Form 4 Trading Tracker

According to the SEC Form 4 filings, Garrett Gruener has made a total of 2 transactions in Nanomix Corp (NNMX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Nanomix Corp is the acquisition of 10,000 shares on December 9, 2022, which cost Garrett Gruener around $2,500.

Insider Trading History of Garrett Gruener

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Garrett Gruener Trading Performance

GuruFocus tracks the stock performance after each of Garrett Gruener's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Garrett Gruener is -20.4%. GuruFocus also compares Garrett Gruener's trading performance to market benchmark return within the same time period. The performance of stocks bought by Garrett Gruener within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Garrett Gruener's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Garrett Gruener

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-2.18
Relative Return to S&P 500(%)	2.95

Garrett Gruener Ownership Network

Ownership Network List of Garrett Gruener

No Data

Ownership Network Relation of Garrett Gruener

Garrett Gruener Owned Company Details

What does Ellie Mae Inc do?

Who are the key executives at Ellie Mae Inc?

Garrett Gruener is the 10 percent owner of Ellie Mae Inc. Other key executives at Ellie Mae Inc include EVP & Technology & Operations Peter Hirsch , 10 percent owner First American Corp , and 10 percent owner Guy P Nohra .

Ellie Mae Inc (ELLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ellie Mae Inc (ELLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ellie Mae Inc (ELLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ellie Mae Inc (ELLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ellie Mae Inc Insider Transactions

No Available Data

What does Raptor Pharmaceutical Corp do?

Who are the key executives at Raptor Pharmaceutical Corp?

Garrett Gruener is the other: No longer 10% owner of Raptor Pharmaceutical Corp. Other key executives at Raptor Pharmaceutical Corp include Chief Medical Officer Krishna R Polu , Chief Financial Officer Michael P Smith , and Chief Commercial Officer David Happel .

Raptor Pharmaceutical Corp (RPTP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Raptor Pharmaceutical Corp (RPTP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Raptor Pharmaceutical Corp (RPTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Raptor Pharmaceutical Corp (RPTP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Raptor Pharmaceutical Corp Insider Transactions

No Available Data

What does NeurogesX Inc do?

Who are the key executives at NeurogesX Inc?

Garrett Gruener is the 10 percent owner of NeurogesX Inc. Other key executives at NeurogesX Inc include President and CEO Ron Martell , Exec. V.P. & COO & CFO Stephen F Ghiglieri , and director & 10 percent owner Robert Nelsen .

NeurogesX Inc (NGSX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeurogesX Inc Insider Transactions

No Available Data

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Garrett Gruener is the other: No longer 10% Owner of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Garrett Gruener made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 186,515 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,783,800 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,783,800 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dynavax Technologies Corp Insider Transactions

No Available Data

What does Cutera Inc do?

Who are the key executives at Cutera Inc?

Garrett Gruener is the 10 percent owner of Cutera Inc. Other key executives at Cutera Inc include EVP & Chief Technology Officer Michael Karavitis , Interim Chief Financial Office Stuart Drummond , and Chief Operating Officer Jeffrey S Jones .

Cutera Inc (CUTR) Insider Trades Summary

Over the past 18 months, Garrett Gruener made no insider transaction in Cutera Inc (CUTR). Other recent insider transactions involving Cutera Inc (CUTR) include a net sale of 63,603 shares made by Michael Karavitis , a net purchase of 30,000 shares made by Taylor C. Harris , and a net purchase of 5,000 shares made by Stuart Drummond .

In summary, during the past 3 months, insiders sold 63,603 shares of Cutera Inc (CUTR) in total and bought 0 shares, with a net sale of 63,603 shares. During the past 18 months, 63,603 shares of Cutera Inc (CUTR) were sold and 35,000 shares were bought by its insiders, resulting in a net sale of 28,603 shares.

Cutera Inc (CUTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cutera Inc Insider Transactions

No Available Data

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Garrett Gruener is the other: See Footnote #2 of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Garrett Gruener made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Garrett Gruener is the other: See footnotes of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Garrett Gruener made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Garrett Gruener is the 10 percent owner of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Garrett Gruener made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 4,500 shares made by Linda Palczuk .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 50,500 shares were bought by its insiders, resulting in a net sale of 53,475 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

What does Nanomix Corp do?

Who are the key executives at Nanomix Corp?

Garrett Gruener is the director & 10 percent owner of Nanomix Corp. Other key executives at Nanomix Corp include Chief Financial Officer Chris Hetterly , director & CEO Thomas Schlumpberger , and Chief Operating Officer Vidur Sahney .

Nanomix Corp (NNMX) Insider Trades Summary

Over the past 18 months, Garrett Gruener made 1 insider transaction in Nanomix Corp (NNMX) with a net purchase of 10,000.

In summary, during the past 3 months, insiders sold 0 shares of Nanomix Corp (NNMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanomix Corp (NNMX) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.

Nanomix Corp (NNMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nanomix Corp Insider Transactions

No Available Data

Garrett Gruener Mailing Address

Above is the net worth, insider trading, and ownership report for Garrett Gruener. You might contact Garrett Gruener via mailing address: One Embarcadero Center, Suite 3700, San Francisco Ca 94111.

Discussions on Garrett Gruener

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.